TARS Latest Press Releases

-- July 13, 2026 --

Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth Globe Newswire 4:05 PM

-- July 8, 2026 --

Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101 Globe Newswire 4:05 PM

-- June 2, 2026 --

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors Globe Newswire 8:30 AM

-- May 28, 2026 --

Tarsus to Participate in Upcoming Investor Conferences Globe Newswire 4:30 PM

-- May 14, 2026 --

Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans Globe Newswire 8:30 AM

-- May 7, 2026 --

Tarsus to Participate in Upcoming Investor Conferences Globe Newswire 5:00 PM

-- May 6, 2026 --

Tarsus Reports First Quarter 2026 Financial Results and Recent Business Achievements Globe Newswire 4:05 PM

-- April 29, 2026 --

Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 Globe Newswire 4:30 PM

-- March 31, 2026 --

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease Globe Newswire 8:30 AM

-- March 23, 2026 --

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus Globe Newswire 8:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software